PL2254873T3 - Związek benzodiazepinowy i kompozycja farmaceutyczna - Google Patents
Związek benzodiazepinowy i kompozycja farmaceutycznaInfo
- Publication number
- PL2254873T3 PL2254873T3 PL09713382T PL09713382T PL2254873T3 PL 2254873 T3 PL2254873 T3 PL 2254873T3 PL 09713382 T PL09713382 T PL 09713382T PL 09713382 T PL09713382 T PL 09713382T PL 2254873 T3 PL2254873 T3 PL 2254873T3
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical composition
- benzodiazepine compound
- benzodiazepine
- compound
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008041296 | 2008-02-22 | ||
| JP2008227368 | 2008-09-04 | ||
| PCT/JP2009/053623 WO2009104819A1 (en) | 2008-02-22 | 2009-02-20 | Benzodiazepine compound and pharmaceutical composition |
| EP09713382.1A EP2254873B1 (en) | 2008-02-22 | 2009-02-20 | Benzodiazepine compound and pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2254873T3 true PL2254873T3 (pl) | 2014-10-31 |
Family
ID=40600203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09713382T PL2254873T3 (pl) | 2008-02-22 | 2009-02-20 | Związek benzodiazepinowy i kompozycja farmaceutyczna |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US8338406B2 (pl) |
| EP (1) | EP2254873B1 (pl) |
| JP (1) | JP5355582B2 (pl) |
| KR (1) | KR101332948B1 (pl) |
| CN (2) | CN103554088B (pl) |
| AR (1) | AR070449A1 (pl) |
| AU (1) | AU2009216079B2 (pl) |
| BR (1) | BRPI0908132A2 (pl) |
| CA (1) | CA2715872A1 (pl) |
| CO (1) | CO6300950A2 (pl) |
| CY (1) | CY1115220T1 (pl) |
| DK (1) | DK2254873T3 (pl) |
| ES (1) | ES2494366T3 (pl) |
| HR (1) | HRP20140796T1 (pl) |
| IL (1) | IL207276A (pl) |
| MX (1) | MX2010009269A (pl) |
| MY (1) | MY156226A (pl) |
| NZ (1) | NZ587157A (pl) |
| PL (1) | PL2254873T3 (pl) |
| PT (1) | PT2254873E (pl) |
| RU (1) | RU2496775C2 (pl) |
| SI (1) | SI2254873T1 (pl) |
| TW (1) | TWI413522B (pl) |
| UA (1) | UA103018C2 (pl) |
| WO (1) | WO2009104819A1 (pl) |
| ZA (1) | ZA201005469B (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2254873T3 (pl) | 2008-02-22 | 2014-10-31 | Otsuka Pharma Co Ltd | Związek benzodiazepinowy i kompozycja farmaceutyczna |
| JP5649577B2 (ja) * | 2009-08-21 | 2015-01-07 | 大塚製薬株式会社 | ベンゾ［ｂ］［１，４］ジアゼピン−２，４−ジオン化合物の製造方法 |
| TWI481601B (zh) | 2009-08-21 | 2015-04-21 | Otsuka Pharma Co Ltd | 含氮化合物及藥學組成物 |
| JP2012184225A (ja) * | 2011-02-18 | 2012-09-27 | Otsuka Pharmaceut Co Ltd | 医薬組成物 |
| EP2701699B1 (en) * | 2011-04-28 | 2019-10-16 | The Broad Institute, Inc. | Inhibitors of histone deacetylase |
| AR090037A1 (es) | 2011-11-15 | 2014-10-15 | Xention Ltd | Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio |
| WO2013072693A1 (en) | 2011-11-15 | 2013-05-23 | Xention Limited | Thieno [2, 3 - c] pyrazoles for use as potassium channel inhibitors |
| WO2014018979A1 (en) | 2012-07-27 | 2014-01-30 | The Broad Institute, Inc. | Inhibitors of histone deacetylase |
| US9914717B2 (en) | 2012-12-20 | 2018-03-13 | The Broad Institute, Inc. | Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors |
| JOP20190086A1 (ar) | 2016-10-21 | 2019-04-18 | Novartis Ag | مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب |
| EA038455B1 (ru) * | 2016-10-26 | 2021-08-31 | Новартис Аг | Новые производные нафтиридинона и их применение в лечении аритмии |
| EP3684767B1 (en) | 2017-09-22 | 2024-04-24 | Jubilant Epipad LLC | Heterocyclic compounds as pad inhibitors |
| WO2019077631A1 (en) | 2017-10-18 | 2019-04-25 | Jubilant Biosys Limited | IMIDAZO-PYRIDINE COMPOUNDS FOR USE AS PAD INHIBITORS |
| BR112020008851A2 (pt) | 2017-11-06 | 2020-10-20 | Jubilant Prodel LLC | composto da fórmula i, processo de preparação de compostos da fórmula i, composição farmacêutica, método para o tratamento e/ou prevenção de várias doenças, uso, método para o tratamento de câncer, método de tratamento de câncer e método para o tratamento e/ou prevenção de câncer e doenças infecciosas |
| SG11202004537UA (en) | 2017-11-24 | 2020-06-29 | Jubilant Episcribe Llc | Heterocyclic compounds as prmt5 inhibitors |
| JP2021510733A (ja) | 2018-01-12 | 2021-04-30 | ケーディーエーシー セラピューティクス，インコーポレーテッドＫｄａｃ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． | がんの処置のための選択的ヒストンデアセチラーゼ３（ｈｄａｃ３）インヒビターと免疫治療剤との組み合わせ |
| BR112020018610A2 (pt) | 2018-03-13 | 2020-12-29 | Jubilant Prodel LLC | Compostos de fórmula i, fórmula ii, fórmula iii, fórmula iv, fórmula v, fórmula vi, ou seus polimorfos, estereoisômeros, tautômeros, profármacos, solvatos e sais farmaceuticamente aceitáveis dos mesmos e uso dos mesmos; processo de preparação; composição farmacêutica; e método para o tratamento e/ou prevenção de várias doenças, que incluem câncer e doenças infecciosas |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3133056A (en) | 1961-05-15 | 1964-05-12 | May & Baker Ltd | N-phenylpiperazine derivatives of tetrahydrobenzodiazepines |
| BE707667A (pl) | 1966-12-14 | 1968-06-07 | ||
| US4001408A (en) | 1966-12-14 | 1977-01-04 | Roussel-Uclaf | Substituted heterocyclic compounds, processes and composition including those |
| US3984398A (en) | 1966-12-14 | 1976-10-05 | Roussel-Uclaf | 1,5-Benzodiazepine-2,4-diones |
| JPH0296133A (ja) * | 1988-10-01 | 1990-04-06 | Fuji Photo Film Co Ltd | ハロゲン化銀カラー写真感光材料 |
| BR9200951A (pt) | 1991-03-21 | 1992-11-17 | Hoffmann La Roche | Compostos, processo para sua producao,preparacoes farmaceuticas e uso |
| US5428031A (en) * | 1991-12-03 | 1995-06-27 | Merck & Co., Inc. | Methods of treating cardiac arrhythmia |
| US5691331A (en) * | 1995-06-07 | 1997-11-25 | Merck & Co., Inc. | N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides |
| US5700797A (en) | 1995-06-07 | 1997-12-23 | Merck & Co, Inc. | N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides |
| GB0008179D0 (en) | 2000-04-05 | 2000-05-24 | Glaxo Group Ltd | Chemical process |
| WO2001010216A1 (en) | 1999-08-09 | 2001-02-15 | Merck & Co., Inc. | Antiarrhythmic compounds |
| MXPA04004500A (es) * | 2001-11-13 | 2004-08-11 | Dimensional Pharm Inc | 1,4-benzodiazepinas sustituidas y usos de las mismas para tratamiento del cancer. |
| EA011087B1 (ru) | 2002-12-20 | 2008-12-30 | Эмджен Инк. | Соединения и фармацевтические композиции для лечения воспалительных заболеваний |
| AR055203A1 (es) | 2005-08-31 | 2007-08-08 | Otsuka Pharma Co Ltd | Derivados de benzotiofeno con propiedades antipsicoticas |
| JP4785881B2 (ja) * | 2007-02-27 | 2011-10-05 | 大塚製薬株式会社 | 医薬 |
| PL2254873T3 (pl) | 2008-02-22 | 2014-10-31 | Otsuka Pharma Co Ltd | Związek benzodiazepinowy i kompozycja farmaceutyczna |
-
2009
- 2009-02-20 PL PL09713382T patent/PL2254873T3/pl unknown
- 2009-02-20 RU RU2010138928/04A patent/RU2496775C2/ru not_active IP Right Cessation
- 2009-02-20 CN CN201310203728.XA patent/CN103554088B/zh not_active Expired - Fee Related
- 2009-02-20 HR HRP20140796AT patent/HRP20140796T1/hr unknown
- 2009-02-20 DK DK09713382.1T patent/DK2254873T3/da active
- 2009-02-20 EP EP09713382.1A patent/EP2254873B1/en not_active Not-in-force
- 2009-02-20 AR ARP090100589A patent/AR070449A1/es unknown
- 2009-02-20 NZ NZ587157A patent/NZ587157A/en not_active IP Right Cessation
- 2009-02-20 SI SI200930958T patent/SI2254873T1/sl unknown
- 2009-02-20 TW TW098105587A patent/TWI413522B/zh not_active IP Right Cessation
- 2009-02-20 PT PT97133821T patent/PT2254873E/pt unknown
- 2009-02-20 AU AU2009216079A patent/AU2009216079B2/en not_active Ceased
- 2009-02-20 MX MX2010009269A patent/MX2010009269A/es active IP Right Grant
- 2009-02-20 WO PCT/JP2009/053623 patent/WO2009104819A1/en not_active Ceased
- 2009-02-20 UA UAA201011248A patent/UA103018C2/uk unknown
- 2009-02-20 CN CN200980105883XA patent/CN101952259B/zh not_active Expired - Fee Related
- 2009-02-20 KR KR1020107021117A patent/KR101332948B1/ko not_active Expired - Fee Related
- 2009-02-20 CA CA2715872A patent/CA2715872A1/en active Pending
- 2009-02-20 JP JP2010533351A patent/JP5355582B2/ja not_active Expired - Fee Related
- 2009-02-20 US US12/918,226 patent/US8338406B2/en not_active Expired - Fee Related
- 2009-02-20 MY MYPI2010003603A patent/MY156226A/en unknown
- 2009-02-20 BR BRPI0908132-1A patent/BRPI0908132A2/pt not_active IP Right Cessation
- 2009-02-20 ES ES09713382.1T patent/ES2494366T3/es active Active
-
2010
- 2010-07-29 IL IL207276A patent/IL207276A/en not_active IP Right Cessation
- 2010-07-30 ZA ZA2010/05469A patent/ZA201005469B/en unknown
- 2010-09-22 CO CO10117060A patent/CO6300950A2/es active IP Right Grant
-
2012
- 2012-08-22 US US13/591,361 patent/US8664217B2/en not_active Expired - Fee Related
-
2014
- 2014-07-01 CY CY20141100482T patent/CY1115220T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201005469B (en) | Benzodiazepine compound and pharmaceutical composition | |
| IL228817A0 (en) | Pharmaceutical compounds | |
| EP2133095A4 (en) | PHARMACEUTICAL COMPOSITION | |
| EP2133094A4 (en) | PHARMACEUTICAL COMPOSITION | |
| EP2224805A4 (en) | PHARMACEUTICAL COMPOSITION | |
| IL211886A0 (en) | Solid pharmaceutical composition | |
| IL232458A0 (en) | Quinolone compound and pharmaceutical preparation | |
| IL208387A0 (en) | Pharmaceutical composition | |
| IL201894A0 (en) | Quinolone compound and pharmaceutical composition | |
| EP2070919A4 (en) | SPIROCHINONE COMPOUND AND PHARMACEUTICAL COMPOSITION | |
| ZA201100871B (en) | Solid pharmaceutical composition | |
| ZA201006224B (en) | Pharmaceutical composition | |
| GB2464200B (en) | Pharmaceutical composition | |
| EP2236145A4 (en) | PHARMACEUTICAL COMPOSITION AND ACTIVE INGREDIENT COMBINATION | |
| GB0817969D0 (en) | Pharmaceutical composition | |
| EP2114404A4 (en) | COMPOUND AND PHARMACEUTICAL COMPOSITION | |
| AP2734A (en) | Pharmaceutical carrier composition and pharmaceutical composition | |
| IL205931A0 (en) | Pharmaceutical composition | |
| AP2007004032A0 (en) | Pharmaceutical carrier composition and pharmaceutical composition | |
| PL2231117T3 (pl) | Kompozycja farmaceutyczna zawierająca benzodiazepinę i/lub pochodne benzodiazepiny | |
| GB0817566D0 (en) | Pharmaceutical composition | |
| GB0817974D0 (en) | Pharmaceutical composition |